Nano-X Imaging adjourns annual shareholder meeting for lack of quorum, reschedules for Sept. 29

By Public Technologies
  • Nano-X Imaging’s 2026 annual shareholder meeting was adjourned on Sept. 17 due to lack of quorum, with under 25% of voting rights represented.
  • The meeting will reconvene on Sept. 29 at 3:00 p.m. Israel time; any shares represented will count as a quorum.
  • The board withdrew Proposal 3 on CEO Erez Meltzer’s request, removing planned equity grants valued at USD 600,000 and USD 28,000.
  • Shareholders will still vote on directors, a share-capital increase, and auditor reappointment; the board flagged the capital item as critical.
  • Proposal 2 was tied to financing flexibility and Nasdaq compliance, citing June 30, 2026 cash levels that raised going-concern doubt.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano-X Imaging Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-100989), on September 17, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.